Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome.

导出 LinkOut

翻译打印收藏纠错

作者： Sophia,Heinrich ^[1] ; Thomas,Austgen ^[2] ; Darko,Castven ^[1] ; Moritz,Hess ^[3] ; Christian,Labenz ^[4] ; Martha,Kirstein ^[1] ; Carolin,Zimpel ^[3] ; Lena,Stockhoff ^[3] ; Benjamin,Maasoumy ^[2] ; Bernd,Heinrich ^[2] ; Hans Heinrich,Wedemeyer ^[2] ; Peter Robert,Galle ^[2] ; Harald,Binder ^[1] ; Marc,Nguyen-Tat ^[4] ; Jens Uwe,Marquardt ^[1]

作者单位： Department of Medicine I, University Medical Center, Mainz, Germany. ^[1] Clinic for Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany. ^[2] Department of Medicine I, University Medical Center, Lübeck, Germany. ^[3] Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center-University of Freiburg, Freiburg Im Breisgau, Germany. ^[4]

关键词 cytokeratin-18 hepatorenal syndrome terlipressin therapy response

主题词人类(Humans);细胞死亡(Cell Death);肝肾综合征(Hepatorenal Syndrome);肝硬化(Liver Cirrhosis)

DOI 10.1002/ueg2.12337

PMID 36441143

发布时间 2023-03-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

United European gastroenterology journal

2023年11卷1期

92-102页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome.

United European gastroenterology journal

相似文献

United European gastroenterology journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome.

United European gastroenterology journal

相似文献

United European gastroenterology journal

相关期刊

检索历史清除